# Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)

> **NCT01385176** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 118 (actual)

## Conditions studied

- Heart Failure
- Congestive Heart Failure

## Interventions

- **DEVICE:** Implant of investigational device system
- **PROCEDURE:** Titration during the randomization phase
- **PROCEDURE:** Titration after the randomization phase
- **DIAGNOSTIC_TEST:** Blood Draw

## Key facts

- **NCT ID:** NCT01385176
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-09-21
- **Primary completion:** 2014-05
- **Final completion:** 2026-06-30
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01385176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01385176, "Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01385176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*